2061
CASE REPORT: We report a patient who developed a DAT-positive hemolytic episode after a red cell (RBC) transfusion was delivered during the infusion of her 17th cycle of oxaliplatin.
 a patient: Subject; developed a DAT-positive hemolytic episode: Effect; a red cell (RBC) transfusion was delivered during the infusion of her 17th cycle of oxaliplatin: Treatment; oxaliplatin: Treatment.Drug; a red cell: Treatment.Drug; infusion: Treatment.Route; transfusion: Treatment.Route; 17th cycle: Treatment.Duration; oxaliplatin: Combination.Drug; a red cell: Combination.Drug
Given event type and trigger, please tell me the arguments of all the listed option. Output format is "name1: role1; name2: role2". 
Event type: adverse event 
  Option: Treatment.Freq, Subject.Population, Combination.Drug, Subject.Gender, Treatment.Duration, Subject, Effect, Treatment, Treatment.Disorder, Subject.Disorder, Treatment.Route, Subject.Race, Treatment.Time_elapsed, Treatment.Dosage, Subject.Age, Treatment.Drug 
Text: {0} 
Answer:
 a patient: Subject; developed a DAT-positive hemolytic episode: Effect; a red cell (RBC) transfusion was delivered during the infusion of her 17th cycle of oxaliplatin: Treatment; oxaliplatin: Treatment.Drug; a red cell: Treatment.Drug; infusion: Treatment.Route; transfusion: Treatment.Route; 17th cycle: Treatment.Duration; oxaliplatin: Combination.Drug; a red cell: Combination.Drug